ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.1500
+0.0100 (7.14%)
At close: Feb 6, 2026
ProPhase Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 5.06 | 6.77 | 34.98 | 122.65 | 79.04 | 14.51 | |
Revenue Growth (YoY) | - | -80.65% | -71.48% | 55.17% | 444.59% | 46.96% |
Cost of Revenue | 4.07 | 6.92 | 19.43 | 51.99 | 37.05 | 9.91 |
Gross Profit | 0.99 | -0.15 | 15.56 | 70.65 | 41.99 | 4.61 |
Selling, General & Admin | 30.43 | 37.89 | 33.44 | 34.39 | 22.49 | 7.5 |
Research & Development | 0.17 | 0.59 | 3.33 | 12.67 | 9.69 | 1.08 |
Operating Expenses | 30.6 | 38.48 | 36.78 | 47.06 | 32.19 | 8.58 |
Operating Income | -29.61 | -38.63 | -21.22 | 23.6 | 9.8 | -3.97 |
Interest Expense | -4.07 | -3.35 | -1.27 | -0.76 | -1.15 | -0.3 |
Interest & Investment Income | - | - | 0.06 | 0.51 | 0.81 | 0.06 |
Other Non Operating Income (Expenses) | 1 | -0.02 | 0.01 | - | - | - |
EBT Excluding Unusual Items | -32.69 | -42 | -22.42 | 23.34 | 9.46 | -4.21 |
Gain (Loss) on Sale of Investments | - | - | 0.02 | -0.43 | -0.41 | 0 |
Gain (Loss) on Sale of Assets | -0.87 | - | - | - | - | 1.89 |
Other Unusual Items | -0.83 | -0.33 | - | - | -3.75 | - |
Pretax Income | -34.38 | -42.33 | -22.4 | 22.91 | 5.31 | -2.31 |
Income Tax Expense | 15.18 | 7.2 | -6.02 | 4.45 | -0.97 | 0.01 |
Earnings From Continuing Operations | -49.56 | -49.53 | -16.38 | 18.46 | 6.27 | -2.33 |
Earnings From Discontinued Operations | 7.86 | -3.84 | -0.4 | - | - | 0.2 |
Net Income | -41.7 | -53.36 | -16.78 | 18.46 | 6.27 | -2.13 |
Net Income to Common | -41.7 | -53.36 | -16.78 | 18.46 | 6.27 | -2.13 |
Net Income Growth | - | - | - | 194.32% | - | - |
Shares Outstanding (Basic) | 4 | 2 | 2 | 2 | 2 | 1 |
Shares Outstanding (Diluted) | 4 | 2 | 2 | 2 | 2 | 1 |
Shares Change (YoY) | 94.70% | 18.92% | -7.74% | 1.40% | 58.63% | 0.27% |
EPS (Basic) | -11.57 | -26.08 | -9.75 | 11.65 | 4.13 | -1.83 |
EPS (Diluted) | -11.64 | -26.08 | -9.75 | 10.24 | 3.95 | -1.83 |
EPS Growth | - | - | - | 158.92% | - | - |
Free Cash Flow | -10.67 | -18.44 | -13.97 | 24.63 | -17.85 | -4.28 |
Free Cash Flow Per Share | -2.96 | -9.01 | -8.12 | 13.21 | -9.71 | -3.69 |
Gross Margin | 19.53% | -2.22% | 44.47% | 57.61% | 53.12% | 31.74% |
Operating Margin | -585.78% | -570.59% | -60.66% | 19.24% | 12.40% | -27.37% |
Profit Margin | -825.00% | -788.24% | -47.97% | 15.05% | 7.94% | -14.64% |
Free Cash Flow Margin | -211.12% | -272.44% | -39.94% | 20.08% | -22.58% | -29.50% |
EBITDA | -24.22 | -32.44 | -15.17 | 28.31 | 13.04 | -3.52 |
EBITDA Margin | - | - | -43.36% | 23.09% | 16.49% | -24.28% |
D&A For EBITDA | 5.39 | 6.19 | 6.05 | 4.72 | 3.23 | 0.45 |
EBIT | -29.61 | -38.63 | -21.22 | 23.6 | 9.8 | -3.97 |
EBIT Margin | - | - | -60.66% | 19.24% | 12.40% | -27.37% |
Effective Tax Rate | - | - | - | 19.40% | - | - |
Advertising Expenses | - | 0.3 | 1.8 | 0.4 | 0.4 | 0.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.